Medicine & Life Sciences
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
22%
Abdomen
16%
Adenocarcinoma
15%
Adrenocortical Adenoma
16%
Anatomy
44%
Biopsy
15%
Carcinoma
20%
Carcinosarcoma
15%
Colorectal Neoplasms
17%
Computed Tomographic Colonography
16%
Endometrial Neoplasms
57%
Fluorodeoxyglucose F18
22%
Gastrointestinal Stromal Tumors
26%
Gynecology
36%
Hepatic Artery
14%
Imatinib Mesylate
25%
Janus Kinase 2
15%
Janus Kinase Inhibitors
15%
Klatskin Tumor
15%
Liver
21%
Lymphoma
38%
Magnetic Resonance Imaging
71%
Malignant Mixed Tumor
16%
Melanoma
37%
Mesentery
30%
Multidetector Computed Tomography
21%
Myocutaneous Flap
16%
Names
21%
Neoplasm Metastasis
44%
Neoplasms
100%
Non-Hodgkin's Lymphoma
18%
Obstetrics
32%
orantinib
21%
Ovarian Epithelial Carcinoma
19%
Ovarian Neoplasms
30%
Pancreatic Neoplasms
53%
Panobinostat
17%
Pelvis
15%
Portal Vein
24%
Positron Emission Tomography Computed Tomography
34%
Positron-Emission Tomography
71%
Radiologists
57%
Rectus Abdominis
18%
Recurrence
17%
Renal Cell Carcinoma
24%
Surgical Flaps
41%
Therapeutics
33%
Thigh
18%
Tomography
73%
Uterine Cervical Neoplasms
46%